Skip to main content
SpringerLink
Log in

Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

This was a controlled prospective study on the use of an immunomodulator drug, levamisole, in the treatment of frequently relapsing, steroid-dependent (FR/SD) idiopathic nephrotic syndrome. The study was started on 1 January 2001 and completed on 31 December 2003. There were two groups: a treatment group who received levamisole (2.5 mg/kg) on alternate days for 1 year and a control group who received low-dose prednisolone only (<0.5 mg/kg) on alternate days for 1 year. There were a total of 56 patients (32 in the treatment group and 24 in the control group). The male to female ratio was 1.66:1 in both groups. The mean age upon initial diagnosis was 3.3 years in the levamisole group versus 4.3 years in the control group. The mean duration from diagnosis to the start of the second line treatment was 3.2 years in the levamisole group versus 2.8 years in the control group. The relapse rate and the total cumulative dose of prednisolone during the year prior to second line therapy was compared to that during the year following the institution of second line therapy in 56 patients. The mean relapse rate was reduced more significantly in the levamisole group. It was reduced by 0.29 versus 0.11 relapses/patient/month in the control group (P =0.0001). The mean cumulative dose of steroids was also reduced more significantly in the levamisole group. It was reduced by 293 versus 102 mg/m2/month in the control group (P <0.0001). Therapy failure was seen in 3/32 (9.4%) in the levamisole group versus 12/24 (50%) in the control group. Of the patients, 20/32 (62.5%) using levamisole were relapse-free in the follow-up year post therapy, while no patient was relapse-free in the control group over the same period. No major adverse effects of levamisole were seen. The cost of levamisole therapy was estimated to be US$ 25 per year for a 20-kg body weight child. Thus, we concluded that levamisole is a highly efficacious, safe and easily affordable initial therapy for FR/SD idiopathic nephrotic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McEnery PT, Strife CE (1982) Nephrotic syndrome in childhood. Management and treatment in patients with minimal change, mesangial proliferation or focal glomerulosclerosis. Pediatr Clin North Am 29:875–894

    PubMed  Google Scholar 

  2. ISKDC (1978) The primary nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney disease in children. Kidney Int 13:159–165

    PubMed  Google Scholar 

  3. Niaudet P (2004) Steroid-sensitive nephrotic syndrome in children. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology. Lippincott Williams and Wilkins, Philadelphia, pp 543–556

  4. Koskimies O, Vilska J, Rapola J Hallman N (1987) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544–548

    Google Scholar 

  5. Szeto CC, Gillespie KM, Mathieeson PW (2000) Levamisole induces interleukin 18 and shifts THI/TH2 balance. Immunology 100:217–222

    Article  PubMed  Google Scholar 

  6. Tanphaichitr P, Tanphaichitr D, Sureeratanan J (1980) Treatment of nephrotic syndrome with levamisole. J Ped 96:490–493

    Google Scholar 

  7. British Association for Pediatric Nephrology (1991) Levamisole for corticosteroid dependent nephrotic syndrome in childhood. Lancet 337:1555–1557

    PubMed  Google Scholar 

  8. Dayal U, Dayal AK, Shastry JC, Raghupathy P (1994). Use of levamisole in maintaining remission in steroid sensitive nephrotic syndrome in children. Nephron 66:408–412

    PubMed  Google Scholar 

  9. Rashid HU, Ahmed S, Fatima N, Khanam A (1996) Levamisole in the treatment of steroid dependent or frequent relapsing nephrotic syndrome in children. Bangladesh Ren J 15:6–8

    Google Scholar 

  10. Al-Saran K, Grisaru S, Stephens D, Arbus G (2001) Levamisole vs. cyclophosphamide for frequently relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 56:289–294

    PubMed  Google Scholar 

  11. Niaudet P, Drachman R, Gangnadoux MF, Broyer M (1994) Treatment of idiopathic nephrotic syndrome with levamisole. Acta Pediatr Scand 73:637–641

    Google Scholar 

  12. Meregalli P, Bianchetti MG, Imoberdorf FG, Lutschg J, Reymond D, Oetliker OH (1994) Levamisole in children with frequently recurring idiopathic nephrotic syndrome. Schweiz Med Wochen Schr 124:801–805

    Google Scholar 

  13. Ksiazek J, Krynski J (2000) Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children. Pediatr Taiwan 41:80–84

    Google Scholar 

  14. Bagga A, Sharma A, Srivastava RN (1998) Levamisole therapy in corticosteroid dependent nephrotic syndrome in children. Pediatr Nephrol 11:415–447

    Article  Google Scholar 

  15. Kemper MJ, Amon O, TimmerMann K, Aldrogge H, Muller Wiefel DE (1998) The treatment with levamisole of frequently recurring steroid sensitive idiopathic nephrotic syndrome in children. Dtsch Med Wochenschr 123:239–243

    PubMed  Google Scholar 

  16. Fu LS, Chi CS (2000) Levamisole in steroid-sensitive nephrotic syndrome children with steroid dependency and/or frequent relapses. Acta Pediatr Taiwan 41:80–84

    Google Scholar 

  17. Drachman R, Schlesinger M, Alon U, Mor J, Etzioni A, Shapira H, Ohali M, Drukker A (1988) Immunoregulation with levamisole in children with frequently relapsing steroid responsive nephrotic syndrome. Acta Paediatr Scand 7:721–726

    Google Scholar 

  18. Alshaya HO, Kari JA (2002) Levamisole treatment in steroid-sensitive nephrotic syndrome. Saudi Med J. 23:1001–1104

    Google Scholar 

  19. Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA (2002) Levamisole: adjunctive therapy in steroid-dependent minimal change nephrotic children. Pediatr Nephrol 17:355–358

    Article  PubMed  Google Scholar 

  20. Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13:602–603

    Article  PubMed  Google Scholar 

  21. Bulugahapitiya DT (1997) Liver toxicity in a nephrotic patient treated with levamisole. Arch Dis Child 76:289

    Google Scholar 

  22. Palcoux JB, Niaudet P, Goumy P (1994) Side effects of levamisole in children with nephrosis. Pediatr Nephrol 8:263–264

    Article  Google Scholar 

  23. Arbeitsgemeinschaft für Pädiatrische Nephrologie (1979) Alternate-day vs. intermittent prednisolone in frequently relapsing nephrotic syndrome. Lancet i:401–403

    Google Scholar 

  24. Durkan A, Hodson E, Willis N, Craig J (2001) Non-corticosteroid treatment for nephrotic syndrome in children. Kidney Int 59:1919–1926

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are thankful to the King Abdulaziz City for Science and Technology (KACST), Saudi Arabia, for financing this study. This manuscript was accepted as a poster for the IPNA meeting at Adelaide, South Australia, 2004. We are indebted to all doctors and nurses of the Pediatric Nephrology Unit, Riyadh Medical Complex, and to Miss Rency Cherian for her valuable secretarial help.

Author information

Authors and Affiliations

  1. Pediatric Nephrology Unit, Riyadh Medical Complex, P.O. Box 52948, 11573, Riyadh, Saudi Arabia

    K. Al-Saran, K. Mirza, G. Al-Ghanam & M. Abdelkarim

Authors
  1. K. Al-Saran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Mirza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Al-Ghanam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Abdelkarim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Al-Saran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Saran, K., Mirza, K., Al-Ghanam, G. et al. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome. Pediatr Nephrol 21, 201–205 (2006). https://doi.org/10.1007/s00467-005-2080-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-005-2080-9

Keywords

Search

Navigation